BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Press Releases

  BlossomHill Therapeutics Doses Patients in the First Cohort of the Phase 1/2 SOLARA Clinical Trial of BH-30643 for EGFR- and HER2-Mutated Non-Small Cell Lung Cancer

  January 23, 2025

   · 

  2 min read
• Press Releases

  ALX Oncology Presents Positive Updated Data from ASPEN-06 Phase 2 Trial Demonstrating Evorpacept Generates Strong Response and Durable Clinical Benefit in Patients with HER2-Positive Gastric Cancer

  January 23, 2025

   · 

  8 min read
• Press Releases

  NOW ENROLLING: CIA’S MASTER’S IN CULINARY THERAPEUTICS

  January 23, 2025

   · 

  3 min read
• 

  Press Releases

  Andersen Disease Market Size to Reach USD 2.1 Billion by 2035, Impelled by Advancements in Gene Therapies

  In the year 2024, 7 key markets of the andersen disease market amounted to USD 1.2 Billion. IMARC Group forecast that the same is expected to reach USD 2.1 Billion for 7MM by 2035, by exhibiting a CAGR of 5.71% during the forecast period, which is 2025-2035

  January 23, 2025

   · 

  9 min read
• 

  Press Releases

  Androgen Insensitivity Syndrome Market Size to Reach USD 674.8 Million by 2035, Impelled Advances in Genetic Testing and Diagnostics

  The androgen insensitivity syndrome market size reached a value of USD 396.1 Million in 2024. Looking forward, IMARC Group expects the top 7 major markets to reach USD 674.8 Million by 2035, exhibiting a growth rate (CAGR) of 4.98% during 2025-2035.

  January 23, 2025

   · 

  6 min read